Shanghai MicroPort Endovascular MedTech Co., Ltd.

SSE:688016.SS

89.23 (CNY) • At close June 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 332.189236.762181.898424.519354.419295.803266.837336.031285.591232.253205.447200.92257.88174.472147.884164.808197.466142.068113.342115.64999.19386.14775.64179.8392.11658.25751.47454.8666.537
Cost of Revenue 100.94587.99453.166104.58184.09478.11263.23373.05469.30260.47951.89452.93757.20343.95832.42234.53939.36229.72724.45523.46720.63217.3916.18116.09319.26813.72212.05823.1860
Gross Profit 231.245148.769128.731319.937270.325217.691203.604262.977216.29171.774153.554147.983200.677130.514115.462130.269158.104112.34188.88692.18278.56168.75759.4663.73772.84844.53539.41631.67466.537
Gross Profit Ratio 0.6960.6280.7080.7540.7630.7360.7630.7830.7570.740.7470.7370.7780.7480.7810.790.8010.7910.7840.7970.7920.7980.7860.7980.7910.7640.7660.5771
Reseach & Development Expenses 15.94119.97922.57823.94323.1953.46741.3840.16836.21849.3635.54718.33934.2935.22626.60219.32521.11332.09918.71513.5378.65420.12710.61111.9796.92211.4445.99411.590
General & Administrative Expenses 20.229-11.29833.981-1.10212.59416.20226.994-1.35613.191-11.21522.574-3.32310.376-7.55314.496-1.0124.508-9.1196.302-0.0923.473-8.0884.5295.1184.224-2.8922.1817.6130
Selling & Marketing Expenses 44.684-12.1960.94535.80626.58341.03425.88138.16725.07343.7125.75214.41920.12423.97121.82911.88917.97924.03717.2359.5478.69722.88915.4298.7878.33215.27312.62812.30
SG&A 64.913-23.48895.64556.50841.50753.03852.87536.81138.26432.49448.32611.09630.516.41836.32510.87722.48614.91823.5379.45612.1714.819.95813.90612.55612.38214.8119.9140
Other Expenses -0.481126.356-154.048-0.36-1.006-2.651-0.005-1.8170.16922.128-25.34812.945-0.745-0.137-1.2750.2780.018-0.020.2944.889-3.6470.0280.012-8.9380.3694.4580.0311.174-28.247
Operating Expenses 80.373125.387-35.82680.81264.697109.15680.61780.48874.651103.98358.52542.38164.04568.1742.94638.56844.40755.64242.54627.88214.70939.34730.59416.94619.84728.28321.131.174-28.247
Operating Income 150.87123.382165.049239.125205.628108.535125.968182.726144.52866.02198.696109.088141.40970.51176.60997.021118.63560.12548.83771.49969.47333.46331.96246.62652.21515.39318.31632.84838.29
Operating Income Ratio 0.4540.0990.9070.5630.580.3670.4720.5440.5060.2840.480.5430.5480.4040.5180.5890.6010.4230.4310.6180.70.3880.4230.5840.5670.2640.3560.5990.575
Total Other Income Expenses Net -0.006-7.4180.025-0.58-1.006-0.165-0.005-1.8170.401-0.717-0.430.018-0.189-0.137-1.2750.2780.018-0.020-0.36200.0280.0120.0300.004000
Income Before Tax 150.86615.965165.074255.823216.761120.518125.963180.909144.92965.30498.266109.106141.2270.37475.33497.299118.65360.10548.83771.13869.47333.49131.97446.65652.21515.39718.31632.84838.29
Income Before Tax Ratio 0.4540.0670.9080.6030.6120.4070.4720.5380.5070.2810.4780.5430.5480.4030.5090.590.6010.4230.4310.6150.70.3890.4230.5840.5670.2640.3560.5990.575
Income Tax Expense 22.8770.39317.47837.6833.89518.10218.48127.09121.37611.12513.54918.02619.1455.69411.20714.2816.9687.8966.97210.0799.9944.2684.4546.2637.5950.8352.72232.881-22.724
Net Income 129.637-51.238149.815219.228184.296104.006108.9154.686124.84155.99585.84791.551123.48565.87165.2883.019101.68552.2141.86561.05959.47929.22227.5240.34844.66514.56215.59427.72432.767
Net Income Ratio 0.39-0.2160.8240.5160.520.3520.4080.460.4370.2410.4180.4560.4790.3780.4410.5040.5150.3670.3690.5280.60.3390.3640.5050.4850.250.3030.5050.492
EPS 1.05-0.421.221.782.231.261.512.151.730.781.21.281.720.90.911.151.410.720.580.850.830.450.380.750.830.270.290.520.61
EPS Diluted 1.05-0.421.221.782.231.261.512.151.730.781.21.281.720.90.911.151.410.720.580.850.830.450.380.750.830.270.290.520.61
EBITDA 151.81716.458165.397267.992217.204132.806140.067194.583156.62586.545110.208120.191152.33478.37383.943103.168124.52264.73553.46774.31372.64844.25731.97446.62654.18217.39418.3165.09166.537
EBITDA Ratio 0.4570.070.9090.6310.6130.4490.5250.5790.5480.3730.5360.5980.5910.4490.5680.6260.6310.4560.4720.6430.7320.5140.4230.5840.5880.2990.3560.0931